The mammalian intestine is colonized by beneficial commensal bacteria and is a site of infection by pathogens, including helminth parasites. Helminths induce potent immunomodulatory effects, but whether these effects are mediated by direct regulation of host immunity or indirectly through eliciting changes in the microbiota is unknown. We tested this in the context of virus-helminth coinfection. Helminth coinfection resulted in impaired antiviral immunity and was associated with changes in the microbiota and STAT6-dependent helminth-induced alternative activation of macrophages. Notably, helminth-induced impairment of antiviral immunity was evident in germ-free mice, but neutralization of Ym1, a chitinase-like molecule that is associated with alternatively activated macrophages, could partially restore antiviral immunity. These data indicate that helminth-induced immunomodulation occurs independently of changes in the microbiota but is dependent on Ym1.
T he microbiota of the mammalian gastrointestinal (GI) tract is composed of trillions of beneficial commensal bacteria that promote nutrient metabolism and regulate multiple physiological processes (1, 2) . The GI tract is also a common site of infection by pathogenic viruses, bacteria, protozoa, and helminths. The dynamic cross-regulation that exists between the host, the microbiota, and enteric pathogens regulates intestinal homeostasis (3) (4) (5) (6) (7) (8) (9) , indicating that these are highly coevolved relationships. Signals derived from commensal bacteria and helminth parasites can influence the mammalian immune response (1, 2, (10) (11) (12) , and helminth infection can elicit alterations in the composition of commensal bacteria that have been associated with limiting inflammation in multiple tissues (13) (14) (15) (16) . Despite speculation regarding whether helminth-induced immunomodulation is mediated through direct effects on the mammalian immune system or indirectly via changes in the microbiota (14, 17, 18) , this fundamental question has not been addressed. Given the impact of helminth-elicited immunomodulation both as a risk factor for bacterial, viral, and protozoan coinfection (19) (20) (21) (22) and as a potential therapeutic strategy for multiple inflammatory diseases including asthma, multiple sclerosis, and inflammatory bowel disease (23, 24) , (E) MNV genome copies in ileal tissue were quantified by real-time polymerase chain reaction (RT-PCR). All data are representative of two to four independent experiments with a minimum of three to five mice per group. Statistics compared monoinfected versus coinfected groups by using the Student's t test. *P < 0.05. LoD, limit of detection.
it is critical to define the regulatory mechanisms by which helminth parasites can influence innate and adaptive immunity. To test whether helminth infection elicits immunomodulation through direct effects on the mammalian immune system or via alterations in the microbiota, we developed a model of enteric coinfection using the helminth parasite Trichinella spiralis (Ts), which inhabits the small intestine for about 2 to 3 weeks before progressing to a persistent extraintestinal phase, and a murine norovirus (MNV CW3) that acutely infects the ileum. As expected, Trichinella infection induced type 2 immune responses ( fig. S1 ). In the presence of the microbiota, Trichinella-MNV coinfection ( fig. S2A ) was associated with decreased frequencies and numbers of MNVspecific CD8 + T cells within the small intestine, Peyer's patches, and spleen compared with monoinfected controls (Fig. 1, A and B, and fig. S2 , B and C). Further, MNV-specific CD8 + T cells isolated from helminth-coinfected mice exhibited diminished polyfunctional effector function as compared with monoinfected controls (Fig. 1C) . Analysis of MNV-specific CD4 + T cells using major histocompatibility complex II (MHCII) IA b tetramers specific for an epitope (P1496) within the MNV capsid (table S1) identified that helminthcoinfected mice also had fewer antigen-specific CD4 + T cells ( fig. S2D ) and impaired accumulation of virus-specific CD4 + T cells expressing both interferon-g (IFN-g) and tumor necrosis factor-a (TNF-a) compared to monoinfected controls (Fig. 1D) . Notably, the defective T cell responses were associated with elevated viral loads in intestinal tissue of Trichinella/MNV CW3-infected mice compared to monoinfected controls (Fig. 1E) .
We generated a recombinant gp33-expressing strain of MNV CW3 (CW3 gp33 ) to track the activation and early proliferation of MNV-specific CD8 + T cells in vivo. Adoptively transferred congenic gp33-specific P14 CD8 + T cells accumulated and exhibited polyfunctional effector function in the intestine and spleen after MNV infection ( fig.  S3 ). Spatial and kinetic analysis of gp33-specific P14 CD8 + T cell activation and proliferation revealed that helminth coinfection resulted in delayed virus-specific CD8 + T cell proliferation and activation ( Fig. 2A) , as well as reduced or delayed accumulation of virus-specific T cells in the draining mesenteric lymph nodes (MLNs) and spleen ( extraintestinal tissues and can influence immunity to multiple viral pathogens. Further, the immunomodulatory effects of helminth infection on antiviral immunity were not restricted to Trichinella and were also evident after infection with Heligmosomoides polygyrus bakeri (Hp) (Fig. 2, F to H) . Despite ongoing clinical trials testing the potential efficacy of helminth immunotherapy to treat inflammatory diseases and the detrimental effects of helminth coinfection on protective immune responses to other human pathogens (19, 21, 23, 24) , the mechanisms underlying helminth-elicited immunomodulation remain poorly understood. Helminth infections can induce shifts in the composition of commensal bacterial communities, and these alterations have been proposed to play a role in modulating the host immune response (13) (14) (15) (16) (17) (18) . Further, commensal bacteria-derived signals can modulate lymphocyte responses to infection (3, 4, 9) , including antiviral immunity (25) (26) (27) . To test whether Trichinella infection altered the composition of the intestinal microbiota, we performed sequencing and phylogenetic analysis of bacterial 16S ribosomal RNA (rRNA) genes of small intestine and colon luminal contents. These analyses revealed alterations in commensal bacterial communities in both the small and the large intestine after Trichinella infection (Fig. 3, A to D) . Notable changes included a reduction in the relative abundance of the Turicibacteraceae family and an increase in the relative abundance of Lactobacillacaeae in the small intestine (Fig. 3C) and increased colonic representation of Clostridiales (Fig. 3D) .
To test whether these alterations contributed to helminth-induced immunomodulation, we compared the influence of helminth coinfection on antiviral immunity in the presence or absence of the microbiota using germ-free (GF) mice. Establishment of Trichinella in the intestine and peripheral tissues and induction of helminth-induced T helper 2 (T H 2) cell responses were similar in conventional (CNV) and GF mice ( fig. S7 ). The diminished antiviral responses seen in helminth-coinfected mice were evident in both CNV and GF mice (Fig. 3, E to G). These data indicate that helminth-elicited immunomodulation of antiviral immunity can occur independently of changes in the microbiota and suggest that coevolution may have resulted in mechanisms that allow helminths to directly regulate host immune responses.
Helminth infection elicits the induction of type 2 cytokines and is associated with signal transducer and activator of transcription 6 (STAT6)-dependent alternative activation of macrophages (AAMacs), but these responses are not typically associated with protective antiviral immune responses. Therefore, we tested whether STAT6-dependent differentiation of AAMacs may underlie the dysregulated antiviral immune response in the context of helminth coinfection. Ex vivo analysis revealed a significant population expansion of macrophages (CD11b + CD11c -cells) in the MLNs of Trichinella-infected mice that was unaltered by MNV infection (Fig. 4A ). Up-regulation of known AAMac-associated genes, including arginase-1 (Arg1), RELMa (Retnla), and Ym1 (Chi3l3), was detected in the ileum of wild-type (WT) but not STAT6-or interleukin-4Ra (IL-4Ra)-deficient mice (Fig. 4B  and fig. S8A ), indicating that AAMac responses were evident in coinfected mice at the site of MNV CW3 infection. Critically, deletion of STAT6 was sufficient to restore MNV CW3 gp33 -induced CD8 + T cell proliferation (Fig. 4C) , and mice lacking STAT6 or IL-4Ra exhibited reduced viral loads compared with coinfected WT controls after MNV infection (Fig. 4D and fig. S8B ). Further, delivery of IL-4/anti-IL-4 complexes was sufficient to induce expression of AAMac-associated genes and impair antiviral immunity in vivo compared with control-treated mice ( fig. S9) . Collectively, these data suggest that AAMacs may limit the induction of host-protective antiviral immune responses in a type 2 cytokine-and STAT6-dependent manner.
Because MNV has tropism for macrophages (28), we tested the ability of bone marrow-derived macrophages (BM-Macs) to control viral replication. After recombinant IL-4 (rIL-4) treatment, BM-IL4 Macs undergo STAT6-dependent alternative activation, and BM-IL4 Macs infected with MNV CW3 gp33 exhibited STAT6-dependent increases in viral burdens compared with control BM-Macs (fig. S10) S11, B and C) . Together, these data indicate that helminth-elicited STAT6-dependent induction of AAMacs can limit innate and adaptive immune responses to enteric viral infection.
AAMac effector molecules arginase-1, RELMa, and Ym1 have been implicated in regulating immunity and inflammation (29) (30) (31) . However, antiviral CD8 + T cell activation remained impaired in helminth-coinfected mice after inhibition of arginase-1 ( fig. S12A) Ym1 is one of the most highly expressed AAMac effector molecules in multiple settings of acute and chronic type 2 cytokine-associated inflammation (32) (33) (34) (35) (36) . Although Ym1 has been implicated in promoting chemoattraction and inflammation (37, 38) , the biological functions of this molecule are not well understood (39) . To test whether Ym1 contributes to helminth-induced immunomodulation, virus-helminth-coinfected mice were treated with an isotype control monoclonal antibody (mAb) or a mAb against Ym1 (anti-YM1). Neutralization of Ym1 in coinfected animals significantly enhanced virus-specific CD8 + T cell proliferation (Fig. 4E) , the polyfunctional capacity of antiviral CD8 + T cells, and the number of virus-specific CD4 + T cells expressing effector cytokines ( fig. S13 ). Anti-Ym1 treatment of coinfected mice was associated with enhanced control of viral replication (Fig. 4F) . Further, although CW3 gp33 -infected BM-Macs stimulated robust P14 CD8 + T cell proliferation, this was inhibited by addition of recombinant Ym1 (rYm1) (Fig. 4G) . rYM1 was also sufficient to inhibit T cell receptor-driven activation and proliferation of purified CD8 + T cells (Fig. 4H) . Taken together, these findings reveal a role for helminth-induced AAMacs and Ym1 in immunomodulation of protective immune responses to concomitant viral infection.
These data identify that helminth coinfection can inhibit antiviral immunity via a pathway of innate immunomodulation. This was independent of changes in the microbiota but associated with induction of potent AAMac responses and Ym1-dependent inhibition of antiviral T cell responses ( fig. S14 ). Therefore, although helminth parasites and commensal bacteria colonize the same niche within the intestine, coevolution of helminths with their mammalian hosts may have resulted in mechanisms that allow direct regulation of the host innate immune system and antiviral immunity independently of changes in the microbiota. These findings, coupled with a report by Reese et al. (40) identifying a critical role for helminth-induced IL-4/IL-13 and STAT6 activity in reactivation of latent g-herpesvirus infection in macrophages, indicate a conserved mechanism of innate immunomodulation in the context of virus-helminth coinfection. The identification of an immunomodulatory role for the AAMac-Ym1 pathway could have implications for the development of helminth-based therapies for multiple chronic inflammatory diseases as well as improved vaccination strategies in helminthinfected individuals.
